Moolec Science

Overview
News
Plant-based Meat?
Product stageSegments
Minimum Viable Product
?
Supplier (technology/ingredients)
?

Moolec Science is a UK-based startup developing affordable alternative proteins using molecular farming technology and is a spinout of Argentina-based bioscience conglomerate Bioceres SA. The company uses plants as bioreactors to produce animal protein expressions by embedding animal protein genes into plants, offering a sustainable and cost-effective alternative to traditional animal farming.

In 2008, Moolec Science produced the world’s first bovine chymosin protein in safflower on an industrial scale and developed a platform around its patented technology, called SPC. The company plans on developing other animal proteins, such as porcine, using soybeans and peas to formulate sustainable meat alternative hybrids. In July 2023, the company developed Piggy Sooy, a molecular farming platform, that claims to deliver four times more pork protein expression from soy seeds than previously estimated. In October 2024, Moolec received the USDA’s Animal and Plant Health Inspection Service (APHIS) approval for its genetically engineered (GE) pea, allowing expanded field trials, seed scaling, and potential commercialization.

In April 2023, Moolec acquired ValoraSoy, a company focused on producing and commercializing functional soy proteins for USD 6 million. The company paid  ~USD 2.5 million in cash, and the rest with its shares in three years based on vesting and business metrics. The acquisition is expected to help Moolec accelerate its growth in the food ingredients industry by expanding its commercial network and complementing its Molecular Farming Platform.

Key customers and partnerships

In August 2021, Moolec Science entered into a partnership with Grupo Insud, a producer of biosimilars and other active ingredients for the Pharmaceutical Industry to research and develop yeast, fungi, and other microorganisms-based ingredients that complement Moolec’s product

 

HQ location:
Gallows Hill, Warwick United Kingdom Warwick GBR
Founded year:
2008
Employees:
11-50
IPO status:
Public
Total funding:
USD 71.0 mn
Last Funding:
USD 21.0 mn (Post IPO Debt; Oct 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.